Theseus Pharmaceuticals Inc (DELISTED) (THRX:DL)
4.06
0.00 (0.00%)
USD |
NASDAQ |
Feb 23, 16:00
Theseus Pharmaceuticals Research and Development Expense (TTM): 47.22M for Sept. 30, 2023
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | 47.22M |
| June 30, 2023 | 47.13M |
| March 31, 2023 | 41.55M |
| December 31, 2022 | 35.70M |
| September 30, 2022 | 30.34M |
| Date | Value |
|---|---|
| June 30, 2022 | 23.91M |
| March 31, 2022 | 21.05M |
| December 31, 2021 | 18.33M |
| September 30, 2021 | 15.79M |
| June 30, 2021 | 12.07M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
12.07M
Minimum
Jun 2021
47.22M
Maximum
Sep 2023
29.31M
Average
27.12M
Median
Research and Development Expense (TTM) Benchmarks
| Karuna Therapeutics Inc (DELISTED) | 364.10M |
| NovaBay Pharmaceuticals Inc | 0.068M |
| Palatin Technologies Inc | 22.80M |
| iBio Inc | 8.141M |
| Theriva Biologics Inc | 14.79M |